Novel 4-alkoxy Meriolin Congeners Potently Induce Apoptosis in Leukemia and Lymphoma Cells
Authors:
- Karina S. KringsKKKarina S. Krings
- Tobias R. WassenbergTWTobias R. Wassenberg
- Pablo Cea-MedinaPCPablo Cea-Medina
- Laura SchmittLSLaura Schmitt
- Ilka LechtenbergILIlka Lechtenberg
- Tanya R. LlewellynTLTanya R. Llewellyn
- Nan QinNQNan Qin
- Holger GohlkeHGHolger Gohlke
- Sebastian WesselborgSebastian Wesselborg
- Thomas J. J. MüllerTMThomas J. J. Müller
Open Access
- 23 December 2024
- Vol. 29 (24) , 6050
Abstract
Meriolins (3-(pyrimidin-4-yl)-7-azaindoles) are synthetic hybrids of the naturally occurring alkaloids variolin and meridianin and display a strong cytotoxic potential. We have recently shown that the novel derivative meriolin 16 is highly cytotoxic in several lymphoma and leukemia cell lines as well as in primary patient-derived lymphoma and leukemia cells and predominantly targets cyclin-dependent kinases (CDKs). Here, we efficiently synthesized nine novel 2-aminopyridyl meriolin congeners (3a–3i), i.e., pyrimeriolins, using a one-pot Masuda borylation-Suzuki coupling (MBSC) sequence, with eight of them bearing lipophilic alkoxy substituents of varying length, to systematically determine the influence of the alkoxy sidechain length on the biological activity. All the synthesized derivatives displayed a pronounced cytotoxic potential, with six compounds showing IC50 values in the nanomolar range. Derivatives 3b–3f strongly induced apoptosis and activated caspases with rapid kinetics within 3–4 h in Jurkat leukemia and Ramos lymphoma cells. The induction of apoptosis by the most potent derivative 3e was mediated by the intrinsic mitochondrial death pathway, as it was blocked in caspase-9 deficient and Apaf-1 knockdown Jurkat cells. However, as recently shown for meriolin 16, derivative 3e was able to induce apoptosis in the Jurkat cells overexpressing the antiapoptotic protein Bcl-2. Since tumor cells often inactivate the intrinsic mitochondrial apoptosis pathway (e.g., by overexpression of Bcl-2), these meriolin congeners represent promising therapeutic agents for overcoming therapeutic resistance.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (270650915/GRK 2158, 417677437/GRK 2578)
- Düsseldorf School of Oncology (270650915/GRK 2158, 417677437/GRK 2578)
- Fonds der Chemischen Industrie (270650915/GRK 2158, 417677437/GRK 2578)
This publication has 58 references indexed in Scilit:
- Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trialsClinical and Translational Oncology, 2021
- Azaindole therapeutic agentsBioorganic & Medicinal Chemistry, 2020
- Novel meriolin derivatives as rapid apoptosis inducersBioorganic & Medicinal Chemistry, 2019
- Sequentially Palladium-Catalyzed Processes2006
- Concise Syntheses of Meridianins by Carbonylative Alkynylation and a Four‐Component Pyrimidine SynthesisAngewandte Chemie International Edition, 2005
- Integrated Modeling Program, Applied Chemical Theory (IMPACT)Journal of Computational Chemistry, 2005
- 3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3Bioorganic & Medicinal Chemistry Letters, 2004
- Meridianins, a new family of protein kinase inhibitors isolated from the Ascidian Aplidium meridianumBioorganic & Medicinal Chemistry Letters, 2004
- A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometryJournal of Immunological Methods, 1991
- Characterization of EBV‐genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non‐Hodgkin lymphomaInternational Journal of Cancer, 1977